1
|
Racines MP, Solis MN, Šefcová MA, Herich R, Larrea-Álvarez M, Revajová V. An Overview of the Use and Applications of Limosilactobacillus fermentum in Broiler Chickens. Microorganisms 2023; 11:1944. [PMID: 37630504 PMCID: PMC10459855 DOI: 10.3390/microorganisms11081944] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Revised: 07/24/2023] [Accepted: 07/27/2023] [Indexed: 08/27/2023] Open
Abstract
The implementation of government regulations on antibiotic use, along with the public's concern for drug resistance, has strengthened interest in developing alternatives not only aimed at preserving animal production but also at reducing the effects of pathogenic infections. Probiotics, in particular, are considered microorganisms that induce health benefits in the host after consumption of adequate amounts; they have been established as a potential strategy for improving growth, especially by stimulating intestinal homeostasis. Probiotics are commonly associated with lactic acid bacteria, and Limosilactobacillus fermentum is a well-studied species recognized for its favorable characteristics, including adhesion to epithelial cells, production of antimicrobial compounds, and activation of receptors that prompt the transcription of immune-associated genes. Recently, this species has been used in animal production. Different studies have shown that the application of L. fermentum strains not only improves the intestinal ecosystem but also reduces the effects caused by potentially pathogenic microorganisms. These studies have also revealed key insights into the mechanisms behind the actions exerted by this probiotic. In this manuscript, we aim to provide a concise overview of the effects of L. fermentum administration on broiler chicken health and performance.
Collapse
Affiliation(s)
- Maria Paula Racines
- Facultad de Ciencias Médicas Enrique Ortega Moreira, Carrera de Medicina, Universidad Espíritu Santo, Samborondón 092301, Ecuador; (M.P.R.); (M.N.S.); (M.A.Š.)
| | - Maria Nicole Solis
- Facultad de Ciencias Médicas Enrique Ortega Moreira, Carrera de Medicina, Universidad Espíritu Santo, Samborondón 092301, Ecuador; (M.P.R.); (M.N.S.); (M.A.Š.)
| | - Miroslava Anna Šefcová
- Facultad de Ciencias Médicas Enrique Ortega Moreira, Carrera de Medicina, Universidad Espíritu Santo, Samborondón 092301, Ecuador; (M.P.R.); (M.N.S.); (M.A.Š.)
| | - Róbert Herich
- Department of Morphological Disciplines, University of Veterinary Medicine and Pharmacy, 040 01 Košice, Slovakia;
| | - Marco Larrea-Álvarez
- Facultad de Ciencias Médicas Enrique Ortega Moreira, Carrera de Medicina, Universidad Espíritu Santo, Samborondón 092301, Ecuador; (M.P.R.); (M.N.S.); (M.A.Š.)
| | - Viera Revajová
- Department of Morphological Disciplines, University of Veterinary Medicine and Pharmacy, 040 01 Košice, Slovakia;
| |
Collapse
|
2
|
D'ambrosio S, Ventrone M, Fusco A, Casillo A, Dabous A, Cammarota M, Corsaro MM, Donnarumma G, Schiraldi C, Cimini D. Limosilactobacillus fermentum from buffalo milk is suitable for potential biotechnological process development and inhibits Helicobacter pylori in a gastric epithelial cell model. BIOTECHNOLOGY REPORTS 2022; 34:e00732. [PMID: 35686014 PMCID: PMC9171443 DOI: 10.1016/j.btre.2022.e00732] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/16/2021] [Revised: 03/31/2022] [Accepted: 04/17/2022] [Indexed: 01/09/2023]
Abstract
L.fermentum from buffalo milk grows efficiently without animal-derived medium components. Highest viable biomass titers can be reached after only 8h improving productivity. L. fermentum is suitable for large scale production: complete biotech approach. L. fermentum demonstrates 60% cell survival after spray drying. L. fermentum from buffalo milk displaces H. pylori in a gastric epithelial cell model.
Probiotics are living microorganisms that give beneficial health effects while consumed, and each strain possesses diverse and unique properties and also different technological characteristics that affect its ability to be produced at large scale. Limosilactobacillus fermentum is a widely studied member of probiotics, however, few data are available on the development of fermentation and downstream processes for the production of viable biomasses for potential industrial applications. In the present study a novel L. fermentum strain was isolated from buffalo milk and used as test example for biotechnological process development. The strain was able to produce up to 109 CFU/mL on a (glucose based) semi-defined medium deprived of animal-derived raw materials up to the pilot scale (150 L), demonstrating improved results compared to commonly used, although industrially not suitable, media rich of casein and beef extract. The study of strain behavior in batch experiments indicated that the highest concentration of viable cells was reached after only 8 h of growth, greatly shortening the process. Moreover, initial concentrations of glucose in the medium above 30 g/L, if not supported by higher nitrogen concentrations, reduced the yield of biomass and increased production of heterolactic fermentation by-products. Biomass concentration via microfiltration on hollow fibers, and subsequent spray-drying allowed to recover about 5.7 × 1010CFU/gpowder of viable cells, indicating strain resistance to harsh processing conditions. Overall, these data demonstrate the possibility to obtain and maintain adequate levels of viable L. fermentum cells by using a simple approach that is potentially suitable for industrial development. Moreover, since often exopolysaccharides produced by lactobacilli contribute to the strain's functionality, a partial characterization of the EPS produced by the newly identified L. fermentum strain was carried out. Finally, the effect of L. fermentum versus H. pylori in a gastric epithelial cell model was evaluated demonstrating its ability to stimulate the response of the immune system and displace the infective agent.
Collapse
Affiliation(s)
- Sergio D'ambrosio
- Department of Experimental Medicine, Section of Biotechnology, Medical Histology and Molecular Biology, University of Campania L.Vanvitelli, via de Crecchio 7, Napoli, 80138 Italy
| | - Michela Ventrone
- Department of Experimental Medicine, Section of Biotechnology, Medical Histology and Molecular Biology, University of Campania L.Vanvitelli, via de Crecchio 7, Napoli, 80138 Italy
| | - Alessandra Fusco
- Department of Experimental Medicine, Section of Biotechnology, Medical Histology and Molecular Biology, University of Campania L.Vanvitelli, via de Crecchio 7, Napoli, 80138 Italy
| | - Angela Casillo
- Department of Chemical Sciences, University of Naples "Federico II", Complesso Universitario Monte S. Angelo, Via Cintia 4, Naples 80126, Italy
| | - Azza Dabous
- Department of Experimental Medicine, Section of Biotechnology, Medical Histology and Molecular Biology, University of Campania L.Vanvitelli, via de Crecchio 7, Napoli, 80138 Italy
- Department of Nutrition and Food Technology, An-Najah National University, P.O. Box 7, Nablus, Palestine
| | - Marcella Cammarota
- Department of Experimental Medicine, Section of Biotechnology, Medical Histology and Molecular Biology, University of Campania L.Vanvitelli, via de Crecchio 7, Napoli, 80138 Italy
| | - Maria Michela Corsaro
- Department of Chemical Sciences, University of Naples "Federico II", Complesso Universitario Monte S. Angelo, Via Cintia 4, Naples 80126, Italy
| | - Giovanna Donnarumma
- Department of Experimental Medicine, Section of Biotechnology, Medical Histology and Molecular Biology, University of Campania L.Vanvitelli, via de Crecchio 7, Napoli, 80138 Italy
| | - Chiara Schiraldi
- Department of Experimental Medicine, Section of Biotechnology, Medical Histology and Molecular Biology, University of Campania L.Vanvitelli, via de Crecchio 7, Napoli, 80138 Italy
| | - Donatella Cimini
- Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania Luigi Vanvitelli, via Vivaldi, 43, Caserta, 81100 Italy
- Corresponding author.
| |
Collapse
|
3
|
Pastor-Villaescusa B, Blanco-Rojo R, Olivares M. Evaluation of the Effect of Limosilactobacillus fermentum CECT5716 on Gastrointestinal Infections in Infants: A Systematic Review and Meta-Analysis. Microorganisms 2021; 9:microorganisms9071412. [PMID: 34208893 PMCID: PMC8305821 DOI: 10.3390/microorganisms9071412] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2021] [Revised: 06/22/2021] [Accepted: 06/26/2021] [Indexed: 12/13/2022] Open
Abstract
Reducing the incidence of gastrointestinal infections (GIs) that occur at early stages to mitigate hospitalizations and treatments with adverse effects is a promising strategy for providing well-being to infants and their families. This systematic review and meta-analysis explores whether the early administration of Limosilactobacillus fermentum CECT5716 might be effective as a preventive therapy for GIs. We reviewed the literature to identify randomized controlled trials (RCTs) investigating the effectiveness of milk formulas supplemented with L. fermentum CECT5716 administered to infants at early stages to reduce the incidence of GIs. The MEDLINE (via PubMed), Web of Science (WoS), and Cochrane Central Register of Controlled Trials (via CENTRAL) databases were searched up to 15 June 2021. GI data from the included studies were synthesized in a random-effects model. Three RCTs were finally selected including 435 infants. There was a significant reduction in the incidence rate of GIs for those receiving L. fermentum CECT5716 compared with those receiving placebo (IRR: 0.52, 95% CI: 0.36-0.74, p = 0.0004). Heterogeneity between studies was moderate (I2 = 54.5%). Based on the present systematic review and meta-analysis, the administration of L. fermentum CECT5716 at doses from 1 × 109 to 8.4 × 108 cfu/day in milk formulas may prevent GIs in infants up to 12 months old. Longer-term studies including a higher number of infants are needed to determine whether the use of this probiotic during the early stages of life is an efficient way to reduce the incidence of GIs.
Collapse
Affiliation(s)
- Belén Pastor-Villaescusa
- Metabolism in Childhood Research Group, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, 14004 Córdoba, Spain;
- Biosearch Life SA, Camino de Purchil 66, 18004 Granada, Spain;
| | | | - Mónica Olivares
- Biosearch Life SA, Camino de Purchil 66, 18004 Granada, Spain;
- Correspondence:
| |
Collapse
|
4
|
Moubareck CA. Human Milk Microbiota and Oligosaccharides: A Glimpse into Benefits, Diversity, and Correlations. Nutrients 2021; 13:1123. [PMID: 33805503 PMCID: PMC8067037 DOI: 10.3390/nu13041123] [Citation(s) in RCA: 39] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2021] [Revised: 03/18/2021] [Accepted: 03/26/2021] [Indexed: 12/12/2022] Open
Abstract
Human milk represents a cornerstone for growth and development of infants, with extensive array of benefits. In addition to exceptionally nutritive and bioactive components, human milk encompasses a complex community of signature bacteria that helps establish infant gut microbiota, contributes to maturation of infant immune system, and competitively interferes with pathogens. Among bioactive constituents of milk, human milk oligosaccharides (HMOs) are particularly significant. These are non-digestible carbohydrates forming the third largest solid component in human milk. Valuable effects of HMOs include shaping intestinal microbiota, imparting antimicrobial effects, developing intestinal barrier, and modulating immune response. Moreover, recent investigations suggest correlations between HMOs and milk microbiota, with complex links possibly existing with environmental factors, genetics, geographical location, and other factors. In this review, and from a physiological and health implications perspective, milk benefits for newborns and mothers are highlighted. From a microbiological perspective, a focused insight into milk microbiota, including origins, diversity, benefits, and effect of maternal diet is presented. From a metabolic perspective, biochemical, physiological, and genetic significance of HMOs, and their probable relations to milk microbiota, are addressed. Ongoing research into mechanistic processes through which the rich biological assets of milk promote development, shaping of microbiota, and immunity is tackled.
Collapse
Affiliation(s)
- Carole Ayoub Moubareck
- College of Natural and Health Sciences, Zayed University, Dubai 19282, United Arab Emirates
| |
Collapse
|
5
|
Lactobacillus fermentum: Could EPS production ability be responsible for functional properties? Food Microbiol 2020; 90:103465. [DOI: 10.1016/j.fm.2020.103465] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2019] [Revised: 12/02/2019] [Accepted: 02/18/2020] [Indexed: 12/15/2022]
|
6
|
Marsaux B, Van den Abbeele P, Ghyselinck J, Prioult G, Marzorati M, Bogićević B. Synbiotic Effect of Bifidobacterium lactis CNCM I-3446 and Bovine Milk-Derived Oligosaccharides on Infant Gut Microbiota. Nutrients 2020; 12:E2268. [PMID: 32751149 PMCID: PMC7468906 DOI: 10.3390/nu12082268] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2020] [Revised: 07/27/2020] [Accepted: 07/27/2020] [Indexed: 01/01/2023] Open
Abstract
BACKGROUND This study evaluated the impact of Bifidobacterium animalis ssp. lactis CNCM I-3446, Bovine Milk-derived OligoSaccharides (BMOS) and their combination on infant gut microbiota in vitro. In addition, a novel strategy consisting of preculturing B. lactis with BMOS to further enhance their potential synbiotic effects was assessed. METHOD Short-term fecal batch fermentations (48 h) were used to assess the microbial composition and activity modulated by BMOS alone, B. lactis grown on BMOS or dextrose alone, or their combinations on different three-month-old infant microbiota. RESULTS BMOS alone significantly induced acetate and lactate production (leading to pH decrease) and stimulated bifidobacterial growth in 10 donors. A further in-depth study on two different donors proved B. lactis ability to colonize the infant microbiota, regardless of the competitiveness of the environment. BMOS further enhanced this engraftment, suggesting a strong synbiotic effect. This was also observed at the microbiota activity level, especially in a donor containing low initial levels of bifidobacteria. In this donor, preculturing B. lactis with BMOS strengthened further the early modulation of microbiota activity observed after 6 h. CONCLUSION This study demonstrated the strong synbiotic effect of BMOS and B. lactis on the infant gut microbiota, and suggests a strategy to improve its effectiveness in an otherwise low-Bifidobacterium microbiota.
Collapse
Affiliation(s)
- Benoît Marsaux
- Center for Microbial Ecology and Technology (CMET), Department of Biotechnology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, 9000 Ghent, Belgium; (B.M.); (M.M.)
- ProDigest BV, Technologiepark 82, 9052 Ghent, Belgium; (P.V.d.A.); (J.G.)
| | | | - Jonas Ghyselinck
- ProDigest BV, Technologiepark 82, 9052 Ghent, Belgium; (P.V.d.A.); (J.G.)
| | - Guénolée Prioult
- Nestlé Research and Development Konolfingen, Nestléstrasse 3, 3510 Konolfingen, Switzerland;
| | - Massimo Marzorati
- Center for Microbial Ecology and Technology (CMET), Department of Biotechnology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, 9000 Ghent, Belgium; (B.M.); (M.M.)
- ProDigest BV, Technologiepark 82, 9052 Ghent, Belgium; (P.V.d.A.); (J.G.)
| | | |
Collapse
|
7
|
Wei Y, Li F, Li L, Huang L, Li Q. Genetic and Biochemical Characterization of an Exopolysaccharide With in vitro Antitumoral Activity Produced by Lactobacillus fermentum YL-11. Front Microbiol 2019; 10:2898. [PMID: 31921073 PMCID: PMC6929415 DOI: 10.3389/fmicb.2019.02898] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2018] [Accepted: 12/02/2019] [Indexed: 12/20/2022] Open
Abstract
In the present study, the whole genome sequence of Lactobacillus fermentum YL-11, a novel exopolysaccharide (EPS)-producing lactic acid bacteria (LAB) strain isolated from fermented milk, was determined. Genetic information and the synthetic mechanism of the EPS in L. fermentum YL-11 were identified based on bioinformatic analysis of the complete genome. The purified EPS of YL-11 mainly comprised galactose (48.0%), glucose (30.3%), mannose (11.8%), and arabinose (6.0%). In vitro, the EPS from YL-11 exhibited inhibition activity against HT-29 and Caco-2 colon cancer cells, suggesting that EPS from strain YL-11 might be used as an antitumoral agent. EPS at 600 and 800 μg/mL achieved inhibition rates of 46.5 ± 3.5% and 45.6 ± 6.1% to HT-29 cells, respectively. The genomic information about L. fermentum YL-11 and the antitumoral activity of YL-11 EPS provide a theoretical foundation for the future application of EPS in the food and pharmaceutical industries.
Collapse
Affiliation(s)
- Yunlu Wei
- College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.,National Engineering Research Center for Fruit and Vegetable Processing, Beijing, China
| | - Fei Li
- College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.,National Engineering Research Center for Fruit and Vegetable Processing, Beijing, China
| | - Le Li
- Department of Environmental and Quality Inspection, Chongqing Chemical Industry Vocational College, Chongqing, China
| | - Linlin Huang
- College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.,National Engineering Research Center for Fruit and Vegetable Processing, Beijing, China
| | - Quanhong Li
- College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.,National Engineering Research Center for Fruit and Vegetable Processing, Beijing, China
| |
Collapse
|
8
|
Naghmouchi K, Belguesmia Y, Bendali F, Spano G, Seal BS, Drider D. Lactobacillus fermentum: a bacterial species with potential for food preservation and biomedical applications. Crit Rev Food Sci Nutr 2019; 60:3387-3399. [PMID: 31729242 DOI: 10.1080/10408398.2019.1688250] [Citation(s) in RCA: 61] [Impact Index Per Article: 12.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Lactic acid-producing bacteria are the most commonly used probiotics that play an important role in protecting the host against harmful microorganisms, strengthening the host immune system, improving feed digestibility, and reducing metabolic disorders. Lactobacillus fermentum (Lb. fermentum) is a Gram-positive bacterium belonging to Lactobacillus genus, and many reportedly to enhance the immunologic response as well as prevent community-acquired gastrointestinal and upper respiratory infections. Additionally, Lb. fermentum strains produce diverse and potent antimicrobial peptides, which can be applied as food preservative agents or as alternatives to antibiotics. Further functions attributed to probiotic Lb. fermentum strains are their abilities to decrease the level of blood stream cholesterol (as cholesterol-lowering agents) and to potentially help prevent alcoholic liver disease and colorectal cancer among humans. Finally, Lb. fermentum is a key microorganism in sourdough technology, contributing to flavor, texture, or health-promoting dough ingredients, and has recently been used to develop new foods stuffs such as fortified and functional foods with beneficial attributes for human health. Development of such new foodstuffs are currently taking important proportions of the food industry market. Furthermore, an increasing awareness of the consumers prompts the food-makers to implement alternative environmental friendly solutions in the production processes and/or suitable biological alternative to limit the use of antibiotics in feed and food. Here, we give an account on the application of Lb. fermentum strains in the biomedical and food preservation fields, with a focus on probiotic features such as bacteriocin production. We also summarize the use of Lb. fermentum as cell factories with the aim to improve the efficacy and health value of functional food.
Collapse
Affiliation(s)
- Karim Naghmouchi
- Department of Pharmaceutical Chemistry, College of Clinical Pharmacy, Al Baha University, Saudi Arabia.,Faculté des Sciences de Tunis, Université de Tunis El Manar, LR01ES05 Biochimie et Biotechnologie, Tunis, Tunisie
| | - Yanath Belguesmia
- Université Lille, INRA, ISA, Université d'Artois, Université Littoral Côte d'Opale, EA 7394-ICV Institut Charles Viollette, Lille, France
| | - Farida Bendali
- Laboratoire de Microbiologie Appliquée, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, Bejaia, Algeria
| | - Giuseppe Spano
- Dipartimento di Scienze Agrarie, degli Alimenti e dell'Ambiente, Università di Foggia, Foggia, Italy
| | - Bruce S Seal
- Biology Program, Oregon State University Cascades, Bend, Oregon, USA
| | - Djamel Drider
- Université Lille, INRA, ISA, Université d'Artois, Université Littoral Côte d'Opale, EA 7394-ICV Institut Charles Viollette, Lille, France
| |
Collapse
|
9
|
Heo J, Shin D, Chang SY, Bogere P, Park MR, Ryu S, Lee WJ, Yun B, Lee HK, Kim Y, Oh S. Comparative Genome Analysis and Evaluation of Probiotic Characteristics of Lactobacillus plantarum Strain JDFM LP11. Korean J Food Sci Anim Resour 2018; 38:878-888. [PMID: 30479496 PMCID: PMC6238035 DOI: 10.5851/kosfa.2018.e21] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2018] [Revised: 07/16/2018] [Accepted: 07/24/2018] [Indexed: 01/05/2023] Open
Abstract
In the current study, the probiotic potential of approximately 250 strains of
lactic acid bacteria (LAB) isolated from piglet fecal samples were investigated;
among them Lactobacillus plantarum strain JDFM LP11, which
possesses significant probiotic potential, with enhanced acid/bile tolerance,
attachment to porcine intestinal epithelial cells (IPEC-J2), and antimicrobial
activity. The genetic characteristics of strain JDFM LP11 were explored by
performing whole genome sequencing (WGS) using a PacBio system. The circular
draft genome have a total length of 3,206,883 bp and a total of 3,021 coding
sequences were identified. Phylogenetically, three genes, possibly related to
survival and metabolic activity in the porcine host, were identified. These
genes encode p60, lichenan permease IIC component, and protein TsgA, which are a
putative endopeptidase, a component of the phosphotransferase system (PTS), and
a major facilitator in the gut environment, respectively. Our findings suggest
that understanding the functional and genetic characteristics of L.
plantarum strain JDFM LP11, with its candidate genes for gut
health, could provide new opportunities and insights into applications in the
animal food and feed additive industries.
Collapse
Affiliation(s)
- Jaeyoung Heo
- International Agricultural Development and Cooperation Center, Chonbuk National University, Jeonju 54896, Korea
| | - Donghyun Shin
- Department of Animal Biotechnology, Chonbuk National University, Jeonju 54896, Korea
| | - Sung Yong Chang
- Department of Animal Science and Institute of Milk Genomics, Chonbuk National University, Jeonju 54896, Korea
| | - Paul Bogere
- Graduate School of Agricultural Convergence Technology, Chonbuk National University, Jeonju 54896, Korea
| | - Mi Ri Park
- Department of Animal Science and Institute of Milk Genomics, Chonbuk National University, Jeonju 54896, Korea
| | - Sangdon Ryu
- Department of Animal Science and Institute of Milk Genomics, Chonbuk National University, Jeonju 54896, Korea
| | - Woong Ji Lee
- Department of Animal Science and Institute of Milk Genomics, Chonbuk National University, Jeonju 54896, Korea
| | - Bohyun Yun
- Department of Animal Science and Institute of Milk Genomics, Chonbuk National University, Jeonju 54896, Korea
| | - Hak Kyo Lee
- Department of Animal Biotechnology, Chonbuk National University, Jeonju 54896, Korea
| | - Younghoon Kim
- Department of Animal Science and Institute of Milk Genomics, Chonbuk National University, Jeonju 54896, Korea
| | - Sangnam Oh
- Department of Functional Food and Biotechnology, Jeonju University, Jeonju 55069, Korea
| |
Collapse
|
10
|
Lemaire M, Dou S, Cahu A, Formal M, Le Normand L, Romé V, Nogret I, Ferret-Bernard S, Rhimi M, Cuinet I, Canlet C, Tremblay-Franco M, Le Ruyet P, Baudry C, Gérard P, Le Huërou-Luron I, Blat S. Addition of dairy lipids and probiotic Lactobacillus fermentum in infant formula programs gut microbiota and entero-insular axis in adult minipigs. Sci Rep 2018; 8:11656. [PMID: 30076313 PMCID: PMC6076243 DOI: 10.1038/s41598-018-29971-w] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2018] [Accepted: 07/23/2018] [Indexed: 02/08/2023] Open
Abstract
Clinical and animal studies have demonstrated beneficial effects of early consumption of dairy lipids and a probiotic, Lactobacillus fermentum (Lf), on infant gut physiology. The objective of this study was to investigate their long-term effects on gut microbiota and host entero-insular axis and metabolism. Piglets were suckled with a milk formula containing only plant lipids (PL), a half-half mixture of plant lipids and dairy lipids (DL), or this mixture supplemented with Lf (DL + Lf). They were weaned on a standard diet and challenged with a high-energy diet until postnatal day 140. DL and DL + Lf modulated gut microbiota composition and metabolism, increasing abundance of several Clostridia genera. Moreover, DL + Lf specifically decreased the faecal content of 2-oxoglutarate and lysine compared to PL and 5-aminovalerate compared to PL and DL. It also increased short-chain fatty acid concentrations like propionate compared to DL. Furthermore, DL + Lf had a beneficial effect on the endocrine function, enhancing caecal GLP-1 and GLP-1 meal-stimulated secretion. Correlations highlighted the consistent relationship between microbiota and gut physiology. Together, our results evidence a beneficial programming effect of DL + Lf in infant formula composition on faecal microbiota and entero-insular axis function.
Collapse
Affiliation(s)
- Marion Lemaire
- INRA, INSERM, Univ Rennes, Nutrition Metabolisms and Cancer, NuMeCan, Rennes, France
- Lactalis R&D, Retiers, France
| | - Samir Dou
- PEGASE, INRA, Agrocampus Ouest, Saint-Gilles, France
| | - Armelle Cahu
- INRA, INSERM, Univ Rennes, Nutrition Metabolisms and Cancer, NuMeCan, Rennes, France
| | - Michèle Formal
- INRA, INSERM, Univ Rennes, Nutrition Metabolisms and Cancer, NuMeCan, Rennes, France
| | - Laurence Le Normand
- INRA, INSERM, Univ Rennes, Nutrition Metabolisms and Cancer, NuMeCan, Rennes, France
| | - Véronique Romé
- INRA, INSERM, Univ Rennes, Nutrition Metabolisms and Cancer, NuMeCan, Rennes, France
| | - Isabelle Nogret
- INRA, INSERM, Univ Rennes, Nutrition Metabolisms and Cancer, NuMeCan, Rennes, France
| | | | - Moez Rhimi
- Micalis, INRA, AgroParisTech, Univ Paris-Saclay, Jouy-en-Josas, France
| | | | - Cécile Canlet
- Toxalim, INRA, Univ Toulouse, ENVT, INP-Purpan, UPS, PF MetaToul-AXIOM, Toulouse, France
| | - Marie Tremblay-Franco
- Toxalim, INRA, Univ Toulouse, ENVT, INP-Purpan, UPS, PF MetaToul-AXIOM, Toulouse, France
| | | | | | - Philippe Gérard
- Micalis, INRA, AgroParisTech, Univ Paris-Saclay, Jouy-en-Josas, France
| | | | - Sophie Blat
- INRA, INSERM, Univ Rennes, Nutrition Metabolisms and Cancer, NuMeCan, Rennes, France.
| |
Collapse
|
11
|
Draft Genome Sequence of Lactobacillus fermentum BFE 6620, a Potential Starter Culture for African Vegetable Foods, Isolated from Fermented Cassava. GENOME ANNOUNCEMENTS 2017; 5:5/33/e00801-17. [PMID: 28818901 PMCID: PMC5604774 DOI: 10.1128/genomea.00801-17] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
We report the draft genome sequence of Lactobacillus fermentum BFE 6620 from fermented cassava used as a potential starter culture for African vegetable fermentation. Sequence analysis showed the assembled genome size to be 1,982,893 bp, encoding a predicted total of 2,003 protein-coding genes, 14 rRNAs, 54 tRNAs, and 3 noncoding RNAs (ncRNAs).
Collapse
|
12
|
Genome Sequence of Lactobacillus fermentum Strain NCC2970 (CNCM I-5068). GENOME ANNOUNCEMENTS 2016; 4:4/6/e01254-16. [PMID: 27856580 PMCID: PMC5114372 DOI: 10.1128/genomea.01254-16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 12/04/2022]
Abstract
Lactobacillus fermentum NCC2970 (CNCM I-5068) is a lactic acid bacterium originating from the Nestle Culture Collection. Here, we disclose its full 1.9-Gb genome sequence comprising one chromosome with no plasmid.
Collapse
|
13
|
Awad M, Ouda O, El-Refy A, El-Feky FA, Mosa KA, Helmy M. FN-Identify: Novel Restriction Enzymes-Based Method for Bacterial Identification in Absence of Genome Sequencing. Adv Bioinformatics 2015; 2015:303605. [PMID: 26880910 PMCID: PMC4735980 DOI: 10.1155/2015/303605] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2015] [Revised: 11/25/2015] [Accepted: 11/29/2015] [Indexed: 12/15/2022] Open
Abstract
Sequencing and restriction analysis of genes like 16S rRNA and HSP60 are intensively used for molecular identification in the microbial communities. With aid of the rapid progress in bioinformatics, genome sequencing became the method of choice for bacterial identification. However, the genome sequencing technology is still out of reach in the developing countries. In this paper, we propose FN-Identify, a sequencing-free method for bacterial identification. FN-Identify exploits the gene sequences data available in GenBank and other databases and the two algorithms that we developed, CreateScheme and GeneIdentify, to create a restriction enzyme-based identification scheme. FN-Identify was tested using three different and diverse bacterial populations (members of Lactobacillus, Pseudomonas, and Mycobacterium groups) in an in silico analysis using restriction enzymes and sequences of 16S rRNA gene. The analysis of the restriction maps of the members of three groups using the fragment numbers information only or along with fragments sizes successfully identified all of the members of the three groups using a minimum of four and maximum of eight restriction enzymes. Our results demonstrate the utility and accuracy of FN-Identify method and its two algorithms as an alternative method that uses the standard microbiology laboratories techniques when the genome sequencing is not available.
Collapse
Affiliation(s)
- Mohamed Awad
- Department of Biotechnology, Faculty of Agriculture, Al-Azhar University, Cairo 11651, Egypt
| | - Osama Ouda
- Department of Information Technology, Faculty of Computer and Information Sciences, Mansoura University, Mansoura 35516, Egypt
| | - Ali El-Refy
- Department of Biotechnology, Faculty of Agriculture, Al-Azhar University, Cairo 11651, Egypt
| | - Fawzy A. El-Feky
- Department of Biotechnology, Faculty of Agriculture, Al-Azhar University, Cairo 11651, Egypt
| | - Kareem A. Mosa
- Department of Biotechnology, Faculty of Agriculture, Al-Azhar University, Cairo 11651, Egypt
- Department of Applied Biology, College of Sciences, University of Sharjah, P.O. Box 27272, Sharjah, UAE
| | - Mohamed Helmy
- Donnelly Centre for Cellular and Biomedical Research, University of Toronto, Toronto, ON, Canada M5S 3E1
| |
Collapse
|
14
|
Abstract
We announce here a draft genome sequence of Lactobacillus fermentum NB-22, a strain isolated from human vaginal microbiota. The assembled sequence consists of 190 contigs, joined into 137 scaffolds, and the total size is 2.01 Mb.
Collapse
|
15
|
Ozen M, Dinleyici EC. Foreword: All things considered about probiotics, prebiotics and ıntestinal microbiota in children – from bench to bedside. Benef Microbes 2015. [DOI: 10.3920/bm2015.x002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
There are numerorus published and ongoing experimental/clinical studies about probiotics and prebiotics, intestinal microbiota and nutrition. Three years ago, at the first International Symposium of Probiotics Prebiotics in Paediatrics in Istanbul (2012) we highlighted the ‘paediatric perspective’ on these issues and brought together more than 40 global key opinion leaders and 400 attendants to have a chance to extensively discuss the past, present and the future. In 2014, the second state of art congress, held in Antalya, aimed to discuss the gut microbiota and microbiotics and their impact through lifespan. Selected papers of this conference are presented in this special issue ‘prebiotics and probiotics in paediatrics’ of Beneficial Microbes. A summary of the conference results is provided below.
Collapse
Affiliation(s)
- Metehan Ozen
- Faculty of Medicine, Department of Paediatrics, Acıbadem University, Istanbul, Turkey
| | - Ener Cagri Dinleyici
- Faculty of Medicine, Department of Paediatrics, Eskisehir Osmangazi University, Eskisehir, Turkey
| |
Collapse
|